Monday, December 12, 2016

Bullish Tactical Take - Improving Strategic Stance


Positive sentiment in back and the market is on the move. The chart below is the S&P 500 on a weekly basis. It would appear that we have broken out of a consolidation phase that has lasted two years and started on a new trend higher.


RSI (14), P&F percent bullish, percent of stocks above their 50DMA and 200DMA all have room for additional upside as they are not yet at extreme over-bought conditions. There was also a recent MACD bullish cross. Given the rise of “animal spirits” and the seasonally strong time of year for equities we are fully invested and remain so at least until the end of the year.
Sentiment indicators are confirming our tactical outlook. University of Michigan Consumer Sentiment Index rose to 98 last week, the highest it’s been since January 2015.
The Sabrient Insider Sentiment Index is an equal- dollar weighted index comprising publicly-traded companies that reflect positive sentiment among those 'insiders' closest to a company's financials & business prospects (top management, directors, analysts). This index recently sprung to a new high but year-over-year is only up 15%. This is far from an overly euphoric number (30% - 40%) that indicated excessive insider optimism.

The shift in sentiment can be seen in many indices. From IBD, “The IBD/TIPP Economic Optimism Index surged to a 10-year high in December, as confidence in the outlook got a jolt from the presidential election and the subsequent stock-market rally.
Economic Optimism rose 3.4 points to 54.8, the highest since November 2006, remaining above the neutral 50 level for the third straight month.”
Anything above the 50 level is economic optimism.
From Merrill Lynch (via Calculated Risk), “Anecdotes and surveys suggest that business and consumer confidence has improved following the election. The gain in animal spirits could amplify the boost to the economy from fiscal stimulus, creating upside risk to our forecast. We will have to wait for the "hard data" from November and December to have clarity on the timing and magnitude.”
From Wells Fargo (also via Calculated Risk), “Small business owners are feeling much more optimistic about the prospects for the economy and their business in the coming year. The latest Wells Fargo/Gallup Small Business Index, which was conducted from Nov. 11 to Nov. 17, jumped 12 points to 80 from the previous quarter and is up 26 points over the past year. Small business optimism is now at its highest level since January 2008, when the index was coming down as the economy slid into recession. The latest reading marks the largest quarterly increase in a little over a year and is one of the largest quarterly gains in the series’ history.
While political factors likely influenced the magnitude of the improvement in small business confidence, business owners’ attitudes about the economy and their business have been gradually improving for the past few years. All of the improvement in the most recent quarter, however, came from the expectations series, which jumped 17 points in the fourth quarter. The present situation index fell 5 points, essentially reversing the prior quarter’s gain.”

Dow Theory Buy Signal
Cam Hui from Humble Student of the Markets and Jeff Hirsch of Almanac Trader both pointed out that both the Dow Industrials and Transports are hitting new highs, thus confirming the current break-out. From Jeff Hirsch, “Well it looks like the Dow Transports just issued a Dow Theory Buy signal by breaking out to a new high on today’s close. The Dow Theory Sell Signal we discussed on January 6 of this year was followed by a further decline of -7.4% on the Dow Jones Industrials.
The current post-election bullish rally looks like it’s got more legs and that further confirms our Best Six Months Seasonal MACD Buy Signal from October 24 and our recent call last week for further gains, based on our bullish scenario for Trump and his new team of policy makers to deliver stimulus, tax cuts, slow rising rates and healthy inflation.”
VIX and Complacency
The VIX is back down under $12 indicating a healthy dose of complacency in the market.
While this is a cautionary sign that the market may be prone to a pull-back, there are a few reasons why I don’t believe this to be the case, at least through the end of the year. The first of course is the new wave of sentiment that is building. This optimism could drive the market higher for the next few weeks or months at least. Additionally, many asset managers (including myself) will use this opportunity to boost their annual returns by trading this rally. That will be fuel for the rally. From Dana Lyons’ Tumblr, “From jacked-up surveys to record ETF inflows, it’s probably safer to conclude that folks are pretty enthusiastic about stocks right now. One specific example comes from the National Association of Active Investment Managers (NAAIM) survey of active manager equity exposure. This week, based on the survey, these active managers have an average of 101.6% exposure to equities. I’d say that’s pretty high.”
“Now, don’t go and sell all of your stocks just yet based on a contrarian analysis of this data point. That’s because the previous “all in” bets by these managers didn’t exactly lead to disastrous results.”
“In fact, on a 3-week, 1-month and 6-month basis, the S&P 500 was higher each time following these >100% readings. And only this past July’s reading led to a negative 3-month return, barely.”
Barron’s pointed out this weekend, “While stocks look overbought in the short term, with three of four stocks already stretching above their 50-day averages, the bullish throng won’t thin now – not when selling after Jan. 1 lets you put off paying capital gains until April 2018, when tax rates just might be lower.”
Thus, the complacency in the VIX number doesn’t mean we should immediately start taking profits. From Dana Lyons’ Tumblr, “what do stocks do after very subdued VIX readings in early December? Specifically, we looked at occasions when the VIX made a 3-month low, as it did today, during the first 18 days of December. While December has generally been a strong month, it has also not been immune to some adversity during the middle part of the month. Therefore, our expectation was that stocks had perhaps struggled following historical occurrences – if not through year-end, at least intra-month. That has not been the case.”
“Since the inception of the VIX in 1986, today marked the 30th time that it hit a 3-month low during the first part of December. Of the prior 29, 27 showed a positive return in the S&P 500 from that date into year-end, with a median return of +0.95%. Even the median drawdown until year-end was very contained, at -0.23%, with just one date seeing a drawdown before year-end of more than -2%.”
The shift in sentiment can absolutely be a powerful yet frustrating event that has the ability to defy even the soundest of analyses. We came across this  article that highlights the power and frustration of market sentiment.
From Business Insider speaking about Albert Edwards of Societe Generale, “Historically, according to Edwards, there has been a close relationship between the Economic Policy Uncertainty Index — which hit an all-time high after Sunday's Italian referendum — and credit spreads (using a mix of US, UK, and euro corporate bonds against their benchmarks): In times of higher uncertainty, global credit spreads have gone up.
Edwards noted that that this relationship, however had been much weaker recently than in the past. Put simply, the debt market hasn't seen a lot of selling or instability even though the outlook for global policy is murkier than it has been in over a decade.
Edwards included commentary from Guy Stear, SocGen's head of emerging markets and credit research. From the note:
"In 2008 and 2011, the correlation between economic policy uncertainty and credit spreads was very close. As uncertainty rose, so did spreads, but something different is happening now. The EPU index is up at all-time highs, but spreads are at the median levels of the period going back to 2008. The chart implies that given the current level of economic policy uncertainty, global spreads should be twice as wide. This ought to worry the bulls."”
“In Edwards' opinion, the credit market is too Pollyannaish. There's the possibility the European Union could break up after the Brexit vote and the Italian referendum, and the election of Trump as US president could bring about either a trade war or a corporate boon. Instead of discounting this risk, Edwards said, the market seems to be simply ignoring it. From Edwards' commentary (emphasis ours):
"Markets shrugged off the Brexit vote in a couple of days. They shrugged off Donald Trump's election in a single day. They shrugged off the Italian Referendum result in a couple of hours. Heck, in this mood they would shrug off an alien invasion of planet Earth. But global political risk is now at such elevated levels that investors must surely be on another planet."
The strategist noted that he had long been worried about the sheer amount of corporate debt floating around. He said, in fact, that the relationship between junk-bond spreads and the amount of debt showed how the credit market had lost touch with reality.
"It is not just the levels of political uncertainty that suggest corporate yields should be considerably above current levels," Edwards wrote. "Normally at this level of corporate debt accumulation, investors have begun throwing their toys out of the pram."”
Long Term Chart
Last year we had gone on alert for the next bear market. The chart below shows how we look at the S&P 500 in a technical way to develop our strategic positioning. On the monthly chart we look for a bearish MACD cross that triggers our warning. From there we look for RSI (14) to break below 50 with the stock falling through the 20-month moving average. Once the 20-month moving average starts sloping negative and the index tests the moving average as resistance and fails…we get out of the market and/or start trading from the short side.
Additionally, we look for the slope in 12-month forward S&P 500 earnings forecasts to start sloping negative. We got that signal in early 2015, coinciding with our technical warning. Earnings did improve somewhat over the next year but took a turn for the worse at the start of 2016 (similar to the 2000 bear market).

Lastly we watch the yield curve for a flattening or inverting of the two and ten year treasury yield. While we didn’t get an inverted yield curve we did experience substantial flattening over the last few years. Given the extreme monetary policies in place we were willing to relax the rule of the inverted yield curve as recessions and bear markets have occurred without an inverted yield curve.
Japan has had five recessions without an inverted yield curve and the US has had six recessions without an inverted yield curve. A common theme among these non-inverted yield curve recessions is that they occurred when underlying rates were low. Central banks have greater power to prevent an inverted curve. We can see today in newly formulated monetary policy agendas in Japan and Europe in which the BOJ and the ECB are attempting to control the steepness of the yield curve.  
We hit most of these conditions starting in 2015 and we have certainly been trading with a defensive posture. In early 2016, we received almost all of our signals for the next correction. We started anticipating a weaker market and we turned out to be wrong. Our returns in March and April of this year underperformed the market as a result.
Our view of the future market activity is still cautious but we are no longer under full bear market alert. On the technical side, RSI (14) is back above 50, the slope of the 20-month moving average is positive again and the index is trading above that level. Probably most importantly we received a bullish MACD cross. Given the new break out from the two-year consolidation we have removed the alert and are now searching for clues of a further “melt up” technically.
The slope of the 12-month EPS consensus has turned positive once again as the earnings recession appears to have ended. Indeed the cut in corporate tax rates proposed by the incoming Trump administration will help earnings per share in our view. In a recent analysis by S&P Global Market Intelligence, they estimated that for every 1% reduction in the corporate tax rate will equate to roughly a 1% increase in corporate earnings. Thus if the Trump administration cuts the tax rate from 35% down to 15%, the current 12-month forward EPS figure for the S&P 500, currently around $131 per share could conceivably jump to $157 per share.  Additionally lowering the repatriation tax to allow US companies to bring in their cash from international holdings would spur additional rounds of share repurchases. This could have a profound impact on equity prices.
The yield curve has steepened since the election as investor deem a business friendly, lower taxes, less regulation, stronger fiscal policy administration to be economically beneficial. Richard Bernstein recently wrote, “The slope of the yield curve is one of the most reliable indicators of future nominal growth. Steeper curves forecast faster nominal growth, flatter yield curves forecast slower growth, and inverted yield curves forecast recession.
Global yield curves are steepening, which supports the forecasts of global leading indicators. Chart 7 shows the percentage of global yield curves that are inverted (i.e., forecasting a recession). In 2008, 41% of global yield curves were inverted. Currently, it is only 2%.  The US yield curve, for example, has been steepening for 5 months.
Steepening global yield curves imply that most investors’ asset allocations are inappropriate, and are too defensively positioned.”
As market technicals improve, corporate earnings accelerate and the yield curve steepens while monetary policy becomes more normalized, the economic policies of the Trump administration could propel the economy and stock prices.
Richard Berstein points out that the global economies are already moving in the right direction. “The global economy might still be in secular stagnation (although we are increasingly doubtful), but cyclical acceleration is clearly underway. Leading economic indicators (LEIs) around the world are strengthening in a unified manner that hasn’t existed since the credit bubble.
Chart 6 shows the relationship between the current global LEIs to those of three months ago. If a country lies above the diagonal line in the chart, then the rate of change in that country’s LEI is stronger than it was three months ago. If a country is below the line, then the rate of change is deteriorating. Most LEIs are improving in unison, which indicates broad improvement in the global economy and an increasing chance of rising interest rates over the next year or so.”
This trend could possibly accelerate as perception becomes reality. Michelle Meyer, chief US economist at Bank of America Merrill Lynch (via Business Insider) states, “"The data clearly show that consumers, investors, and business CEOs have all become more optimistic since the election," Meyer wrote in a note to clients on Thursday.
Things such as regional manufacturing indexes, consumer confidence surveys, and investor sentiment have ticked up since November 8. The only survey that has slid is the ISM-adjusted Empire Manufacturing Survey, which measures the confidence of manufacturers in New York state.
"Bottom line: Most business activity surveys point to greater confidence following the election," Meyer wrote.”
“This sort of upswing in confidence usually starts to show up outside of surveys and in real data in a short amount of time, according to Meyer's analysis. The increases in business indexes usually point to an increase in capital expenditures, while the consumer confidence indicators can predict consumer spending.”

“Some of the correlations are weaker than others, Meyer said, but directionally they point to higher output for the US economy.

"Overall, we see a significant relationship between surveys and actual output, but we would be careful given lags and historical episodes with misleading signals," Meyer wrote.”

We will be watching the data closely.

Bottom Line: In the short-term we are fully deployed and believe this “Trump rally” can last through January. Longer-term, we have exited our cautionary stance on the market and are reconfiguring the portfolio to tilt more towards GARP (growth at a reasonable price) strategy, away from an overly defensive posture.


Joseph S. Kalinowski, CFA




Twitter: @jskalinowski

Facebook: https://www.facebook.com/JoeKalinowskiCFA/

Blog: http://squaredconcept.blogspot.com/

Web Site: http://www.squaredconcept.net/







No part of this report may be reproduced in any manner without the expressed written permission of Squared Concept Asset Management, LLC.  Any information presented in this report is for informational purposes only.  All opinions expressed in this report are subject to change without notice.  Squared Concept Asset Management, LLC is a Registered Investment Advisory and consulting company. These entities may have had in the past or may have in the present or future long or short positions, or own options on the companies discussed.  In some cases, these positions may have been established prior to the writing of the particular report. 

The above information should not be construed as a solicitation to buy or sell the securities discussed herein.  The publisher of this report cannot verify the accuracy of this information.  The owners of Squared Concept Asset Management, LLC and its affiliated companies may also be conducting trades based on the firm’s research ideas.  They also may hold positions contrary to the ideas presented in the research as market conditions may warrant.

This analysis should not be considered investment advice and may not be suitable for the readers’ portfolio. This analysis has been written without consideration to the readers’ risk and return profile nor has the readers’ liquidity needs, time horizon, tax circumstances or unique preferences been taken into account. Any purchase or sale activity in any securities or other instrument should be based upon the readers’ own analysis and conclusions. Past performance is not indicative of future results.

Tuesday, December 6, 2016

Stock Ideas for the New Year


As we prepared for 2017, we will be looking for stock ideas to add to the portfolio. Over the next few weeks we will highlight a few of the companies that have piqued our interest. This report will highlight Constellation Brands Inc. (STZ) and Edwards Lifesciences Corp. (EW).



Constellation Brands Inc (STZ)



Company obviously has had a tough time with its stock price. They are expected to earn $7.17 over the coming twelve months and currently trading 20.8x that figure. Certainly not a deep value valuation here but the company is expected to grow earnings 37% over the next year sporting a 0.6 PEG ratio.


The fundamental slope is positive and extra weight should be applied to the balance sheet valuation metric or book value yield.


Our valuation variance is at levels that have preceded major stock price acceleration in the past.



We’re placing a fair value figure on the stock price at $180 or roughly 22% higher from these levels.



Our valuation yield rate of change is confirming the buy signal.

We will start to accumulate a position at these levels. Optimally if we were to see the stock fall further to $135-$140 per share that would be exciting.


Hedge Fund Wine, Beer Interest Bobs at 6%; Constellation Leads

12/01/16 - Main Report Activists Cool to Beverage Group for Now.

Hedge funds held a median 7% of the outstanding shares of U.S. companies in the Bloomberg Intelligence North America beverage group, as of the latest filings. Constellation Brands had the highest hedge-fund ownership at 22%, followed by Molson Coors Brewing (16%) and Boston Beer (14%). Short interest as a percentage of float was the highest for Boston Beer, at 23%. The group's best-performing one-year stock gain was generated by National Beverage (up 21%).



Constellation Brands to Join High Grade Gauge on Fitch Upgrade

11/18/16 - Constellation Brands Senior Unsecured Bond Ratings.

Fitch followed S&P in upgrading Constellation Brands' senior unsecured notes one notch to BBB-, the lowest investment grade level, on exposure to above-average market growth in the beer, wine and spirits segments, and Fitch's expectation that Constellation will maintain a 3.5x leverage target. The upgrade will trigger the transition of $3.35 billion of outstanding debt from the Bloomberg Barclays U.S. Corporate High Yield Bond Index to the high grade counterpart on the Nov. 30 index rebalancing.

Methodology: Based on Bloomberg Barclays corporate bond indices' methodology, security ratings are assigned using the middle rating of Moody's, S&P and Fitch. Moody's currently has a junk rating on Constellation but said it has put the company on review for upgrade.

U.S. Beer Sales Up 4%; Bud Light Boosted by Water-Melon-Rita

11/16/16 - Main Report IRI Nov. 6 Spirits, Suds and Soda Update.

U.S. beer sales rose 3.8% in the four weeks ended Nov. 6, based on all-channel IRI data, on 2% higher volumes. The positive performance represents a recovery following a 2.6% decline in 3Q industry sales to retailers, reflecting in part a slowing in the craft-beer segment, according to market leader Anheuser-Busch InBev. AB InBev's Bud Light held a leading 17.4% dollar-based U.S. brand share in the period, helped by the success of its new flavor variants, especially watermelon.

Wine Sales Up 4%, Direct-to-Consumer Sales Supporting Growth

11/16/16 - U.S. Wine Trends.

U.S. wine sales rose 4% in the four weeks ended Nov. 6, based on IRI data. Winemaker direct-to-consumer sales are supporting industry growth: Napa, California-based Crimson Wine Group reported a 13% year-over-year increase in net sales in 3Q, reflecting a 23% jump in direct-to-consumer sales and a 3% rise in traditional sales to wholesalers. E&J Gallo held a leading 21.2% IRI dollar-based share of the U.S. wine market in the period, followed by Constellation Brands (15.2%).

Spirits Sales Rise 4%; Jameson's Irish Whiskey Powering Gains

11/16/16 - U.S. Spirits Trends.

U.S. spirits sales rose 3.6% in the four weeks through Nov. 6 vs. a year earlier, led by a 2.2% increase in unit volume, IRI data show. The $2.1 billion U.S. Irish whiskey segment is contributing to the growth, with Pernod Ricard's Jameson brand leading the way. Its recent launch of Jameson Cooper's Croze, which is matured in virgin American oak, seasoned Bourbon and Iberian sherry barrels, has been well received by the market, according to Shanken's Impact.

Constellation Brands

11/09/16 - (Bloomberg Intelligence) -- Constellation Brands Inc.'s planned sale of Canadian wine operations is an extension of its long-standing strategy to expand margins through a focus on premium-priced brands. The company is transforming to build on its position as one of the largest and most diversified operators serving the U.S. alcoholic beverage market. Management expects to generate EPS growth of 16-19% in the fiscal year ending Feb. 28, led by strong sales and profit gains in its beer business.

Constellation Brands' sales may be challenged by the potential for Trump administration-led increase in tariffs on Mexican imports, and the approximate 15% drop in the value of the Mexican peso vs. the U.S. dollar in 2016 through Nov. 9.

Constellation Beer Sales Face Threat of Trump Tariff, Forex Risk

11/09/16 - Constellation Brands' ability to sustain rising beer segment sales is at risk given the potential for higher tariffs on Mexican imports and the 15% plunge in the Mexican peso vs. the U.S. dollar in 2016 through Nov. 9. Constellation derived about 55% of its net sales from its Mexican beer business in the fiscal year ended February. The peso's deterioration reflects in part its low expectations for economic growth and Republican President-elect Donald Trump's views on trade and immigration.

Constellation Brands said on Oct. 5 that it expected its beer business to generate as much as 17% growth in fiscal 2017, and operating profit growth at the "high teens" level.

Corona Extra, Modelo Especial Driving Constellation Sales Growth

10/06/16 - Constellation Brands' Three-Year Net Sales Trend.

Constellation Brands' net sales may rise at a low-teen pace for its fiscal year ending Feb. 28, based on consensus. Growth may be led by further beer segment gains, which grew 20% in 1H vs. the prior year. The segment is being driven mainly by market share inroads for its Corona Extra and Modelo Especial brands. Wine and spirits sales may rise at a middle single-digit pace, supported by organic volume growth and recent acquisition contributions. Consolidated organic net sales grew 11% in 1H.

Segments: Constellation Brands' Beer segment accounted for 55% of fiscal 2016 sales. The Wine & Spirits segment accounted for the remaining 45%, with wine contributing 40%, spirits 5%.

Constellation Operating Margin Boosted by Improving Sales Mix

10/06/16 - Constellation Segment Operating Margin Trends.

Constellation Brands' operating margin may widen to about 30% for the fiscal year, up from 28.5% in the prior year, based on consensus. The expansion may be led by the strong performance of the beer segment, which is benefiting from a more-profitable product mix and operating efficiency gains. Wine and spirits segment margins may widen as well, supported by volume growth and an improved sales mix. Constellation's 1H operating margin widened to 30% from 28.4% in the prior year.

Peer Comparison: Constellation Brands' fiscal 2016 operating margin of 28.5% was well above that of the BI North America beverages peer group's 15.3%, largely reflecting the company's focus on premium brands and rising operating efficiencies.

Corona Extra, Acquisitions Powering Constellation Profit Growth

10/06/16 - Constellation Brands Segment Profit Trends (TTM).

Constellation Brands' operating profits may climb at a high-teen pace in its fiscal year ended on Feb. 28, 2017, versus the prior year, based on consensus. The rapid growth may be powered mostly by an approximate 20% advance for its Beer segment, boosted by strong organic sales growth and an improving product mix toward premium priced brands. Wine and Spirits segment operating profits may rise at a single-digit rate, supported by its recent Meiomi and The Prisoner wine brands acquisitions.

Segments: Constellation Brands' Beer segment made up 63% of profit in fiscal 2016 vs. 60% in the prior year. The Wine and Spirits segment accounted for the remainder.

Corona Fuels Constellation Brands' Higher EPS Outlook: 2Q Review

10/05/16 - Main Report Constellation Brands Earnings Summary.

Key Points:

  • Constellation Fiscal 2Q EPS Beat Consensus by 7%, In-Line with Its Average 8% EPS Positive Surprise in Past Three Years.
  • 2Q Beer Shipment Volume Increased 15%, Above 13% Average Pace Over Past Three Years.
  • Wine and Spirits Segment Shipments Rose 7%, Above Three-Year Average 2% Pace.
  • 2Q Adjusted Operating Margin Widened to 30.2% vs. 28.9% in Prior Year, Reaching New Decade High.

Constellation Brands raised its full-year fiscal 2017 comparable EPS growth expectation after posting wider company margins, a 5% organic sales gain in wine and spirits in 1H and a 15% bump in organic sales of beer, spurred by the popularity of Corona. The company now expects EPS gains of up to 19% this year compared with 17% previously, off the prior year's $5.43. Priorities in 2H include integrating recent M&A. The company announced Oct. 5 it will acquire craft whiskey-maker High West Distillery for $160 million.



A Bottle of Red, a Bottle of White: More Growth Ahead

06/03/16 - Global Wine Categories by Volume.

Global wine volume may increase 2.5% annually through 2020, with still, light wines, which contain 8-14% alcohol by volume, growing 15%. This segment accounts for 77% total sales, according to Euromonitor. Red wines (41% market share) may grow 17.8%, led by steady demand for premium varietals, such as Cabernet Sauvignon, in the U.S., western Europe and Asia. White wines (29%) are also growing, supported by the U.S. and emerging markets. Leading vintners include E&J Gallo Winery and Constellation Brands.





Edwards Lifesciences Corp (EW)


EW is expected to earn $3.37 over the coming twelve months and currently trading 24.5x that figure. The company is expected to grow earnings 35% over the next year with a 0.7 PEG ratio.

The fundamental slope is positive and extra weight should be applied to the balance sheet valuation metric or book value yield as well as the cash flow metric.


Our valuation variance is at levels that have preceded major stock price acceleration in the past.


We’re placing a fair value figure on the stock price at $112 or roughly 36% higher from these levels.


Our valuation yield rate of change is confirming the buy signal.


We would like to see it below $80 and start building a position.




BI Company Primer: Edwards Lifesciences

11/22/16 - (Bloomberg Intelligence) -- Edwards Lifesciences Corp. enters a critical year in 2017 as it faces surgeons hesitant to refer less-sick patients for its transcatheter heart valve therapy and increased competition later in the year. The company may have sole advantage of the intermediate risk indication in the U.S. until 2H, a market that could be worth as much as $1.4 billion. Medtronic and Boston Scientific are on pace to launch new heart valves in late 2017 in the U.S. that could take share from Edwards, pressuring sales in 2018.

Edwards is the leader of the $2 billion transcatheter heart valve segment, with 70% market share in the U.S., according to Millennium Research Group. The company is developing transcatheter mitral valves, a market with up to 3x as many patients as aortic, that could drive future sales.

Key Points:

  • Revenue: Edwards Sales Growth May Top Peers on Strong Heart Valve Demand
  • U.S. Market: U.S. TAVR Market May Be Just 53% Penetrated, More Room to Grow
  • U.S. Market: Edwards Heart Valve Approval May Open $1.4 Billion U.S. Market

Edwards Sales Growth May Top Peers on Strong Heart Valve Demand

11/22/16 - Edwards Lifesciences Revenue Growth %

Edwards Lifesciences may record the strongest sales growth among large-cap device makers in 2016 due to strong demand for its less-invasive transcatheter valves. The company accelerated revenue growth to 17% in 2015, excluding currency, and has increased sales at a 17% pace since launching its Sapien valve in the U.S. in 2011. Approval for the intermediate risk indication in 3Q may sustain double-digit growth long-term, but visibility is limited for 2017, given surgeons are hesitant to refer patients.

Segments: Edwards derives about 55% of revenue from transcatheter heart valves. The company expects the unit's sales this year to expand by more than 30% vs. 2015. Surgical heart valves account for about 25%, followed by critical-care monitoring devices at almost 20%.

Strong Heart Valve Sales May Sustain Margin Growth for Edwards

 11/22/16 - Edwards Adjusted Operating Margin %

Strong transcatheter heart valve sales may help Edwards Lifesciences increase its operating margin in 2016 even as the company boosts R&D spending. In 1Q, Edwards said it was adding more manufacturing capacity to support the launch of its valves for intermediate-risk patients in 2H, which may cut its gross margin 100 bps vs. 2015. Edwards may continue to improve its margin over the next few years as strong sales from new product launches could cover low incremental costs.

Peer Comparison: Edwards Lifesciences's operating margin of 26.4% is above Boston Scientific's 24% and just below Medtronic's 27%. Zimmer Biomet still ranks higher than Edwards at 30%.

Operating Profit, Cash Flow Growth Remains Strong for Edwards

11/22/16 - Edwards Lifesciences may continue to increase operating income in the teens over the next few years as the company launches its transcatheter heart valves for the intermediate- and low-risk indications. Operating income has grown at a 16% annual pace since 2012 as it launched its Sapien valve in the U.S. with few incremental costs. That has driven free cash flow growth over 20% a year during the same time frame, but most of that cash is outside the U.S. and can't be used for share buybacks.

Segments: Transcatheter heart valves may be contributing a majority of operating profit now that they generate 55% of revenue. Surgical valves are likely very profitable, but generate about 25% of sales and profit contribution may decline as transcatheter valve sales cannibalize surgical therapies.

Transcatheter Heart Valve Market May Grow 20% Through 2021

11/22/16 - Edwards Lifesciences expects the transcatheter aortic valve market to grow at a 20% annual pace through 2021 to $5 billion globally, driven by new indications and product launches. Medtronic recently increased its outlook for the market to reach $4-4.5 billion by 2020. Edwards' view may be higher due to approval of low-risk patients in additional countries. The expansion to two new indications may support double-digit sales growth for Edwards over the next few years.

Methodology: Neither company has disclosed assumptions for underlying valve prices, which could also be a reason for differences. Prices have held stable at about $30,000 so far, but competition could cause this to decline with more approvals coming in the next few years.

Intermediate Risk Helps Edwards, Competition Heats Up in 2018

11/22/16 - Edwards Lifesciences has an edge as the only company approved for the intermediate risk indication in the U.S., but competition is likely to enter in all of its indications by late 2017. Medtronic may also get intermediate risk approval in 2H17, while Boston Scientific is expected to enter the extreme and high-risk markets in the U.S. late 2017, possibly taking share from Edwards and Medtronic. Edwards may launch its Sapien 3 Ultra valve in Europe 2H, which could stem some sales losses.

Competition may heat up in Europe in 2017, as well, as Boston Scientific may launch additional sizes for its Lotus Edge valve by midyear. It may take Boston some time to train hospitals in the use of its valve, indicating more pressure on Edwards' sales in 2018.

Edwards Spends Most of Cash on Buybacks, No Dividend in Picture

11/22/16 - Edwards Lifesciences has spent more on share repurchases than its peers given it prefers to develop products internally rather than through mergers and acquisitions. The company has spent 65% of its cash on buybacks since 2011 vs. a 38% average for its cardiovascular peers. Edwards doesn't pay a dividend given its focus on product development as a growth company. The company's leadership in transcatheter heart valves may help it continue to increase cash flow, giving it flexibility for buybacks or M&A.

Edwards expects to generate $500-$600 million of free cash flow in 2016, up from $447 million in 2015, driven by strong sales growth for the company's transcatheter heart valves.

Edwards Seeks Repeat of Early Stage M&A Success, Mitral Tougher

11/22/16 - Edwards Lifesciences may be trying to replicate prior success with early stage M&A with its $350 million purchase of transcatheter mitral valve maker CardiAQ, Edwards's largest deal ever. Edwards bought access to its Sapien transcatheter aortic valve in 2003 for $125 million, a device that has generated more than $5 billion of revenue for the company since 2007. CardiAQ may be the first to launch a device transfemorally (via the leg), though mitral may be tougher than aortic due to more complex anatomy.

Edwards' Sapien Launch Disappoints, May Take Time: 3Q Review

10/26/16 - Main Report Edwards Lifesciences Earnings Summary

Key Points:

  • U.S. TAVR Growth Slows to 58% in Spite of Intermediate-Risk Launch | BI »
  • International TAVR Sales Growth Slows as Medtronic May Have Gained Share | BI »
  • Surgical Valve Sales Flat as TAVR May Be Cannibalizing | BI »
  • Edwards Raises EPS Outlook 1%, Implies 4Q EPS Below Consensus | GUID »
  • Edwards May Give Timing of Mitral Valve Data at Dec. 8 Analyst Meeting | EVTS »

Edwards Lifesciences reported disappointing 3Q sales as its U.S. transcatheter valve revenue growth slowed despite launching its Sapien 3 valve for intermediate-risk patients. Management attributed the slow rollout to physicians and surgeons being hesitant to refer lower-risk patients for transcatheter therapy. U.S. transcatheter valve launches have often started slowly for Edwards, disappointing in 2012 and 2013, but sales then exceeded consensus in 2014-15 due to reimbursement and clinical data.

U.S. TAVR Market May Be Just 53% Penetrated, More Room to Grow

09/09/16 - Main Report Edwards, Medtronic Enter New Era on Intermediate Risk

The U.S. transcatheter heart valve market was just 38% penetrated in 2015 for approved indications and may reach 53% this year, based on company guidance and sales trends in 1H. That means there is room for more growth aside from indication expansion for Edwards Lifesciences and Medtronic. Strong demand for the therapy may indicate more patients previously denied surgery are being diagnosed and getting treated. That could support sales growth in the teens through 2020.

Methodology: The analysis assumes 40% of patients with severe aortic stenosis are denied surgery and that 33% of surgical patients are deemed high risk. The 2016 penetration is based on the midpoint of sales guidance for Edwards Lifesciences and Medtronic's current sales annualized.

Edwards Heart Valve Approval May Open $1.4 Billion U.S. Market

09/09/16 - The intermediate risk indication for transcatheter aortic valves may be worth as much as $1.4 billion in the U.S., based on a BI analysis. Medtronic's projections suggest the indication may be worth $1.5 billion globally by 2020. The market may top the company's expectation if diagnosis rates exceed 50%, which may be reasonable given the stronger-than-expected demand for the therapy so far. Surgeons also have flexibility in defining intermediate risk, which could increase the market size.

Companies Impacted: The FDA has said one-third of surgery patients are intermediate risk, but some physicians have said up to 50% may be in that category. Edwards Lifesciences is the only company with U.S. approval for the intermediate risk indication, while Medtronic expects to launch in this market in 2H17.

Edwards Has Trained Large Hospital Base, May Support More Growth

09/09/16 - The larger-than-expected number of U.S. hospitals trained for transcatheter heart valve therapy and shorter stays may provide more capacity to support more patients due to indication expansion. Edwards Lifesciences has trained 450 hospitals as of 2Q and may soon reach 500, above its initial peak estimate of 400. Hospital stays have fallen from six days to four days in the U.S. from 2013-15, aided by a less-invasive form of sedation. That frees up beds and improves profitability.

Companies Impacted: The use of conscious sedation, used in 25% of cases in 4Q, has been shown to significantly cut the risk of death and stroke while shortening lengths of stay. Edwards got the first approval for the intermediate risk indication on Aug. 18, while Medtronic may do so 2H17.

Low-Risk Valve Label May Disappoint Edwards, Medtronic in 2019

09/09/16 - Edwards Lifesciences and Medtronic may be on track to get U.S. approval for the low-risk indication for transcatheter heart valves by 1Q19, assuming the FDA doesn't require an advisory panel. Edwards expects to complete enrollment of its study in mid-2017, with Medtronic likely right alongside, given both started their trials at the same time. The trials both have initial data available at one-year of follow-up, indicating late 2018 release and possible approval in early 2019.

If 50% of surgical patients are deemed intermediate risk rather than the 33% being touted by Medtronic and the FDA, the low-risk approval may expand the market just $450 million. Cardiologists have shown a tendency to be more aggressive with transcatheter therapies in the past.

Edwards Gains More U.S. TAVR Share as Market Growth Accelerates

08/29/16 - Main Report Demand Remains Strong in 2Q, New Products Critical

Edwards Lifesciences gained another 150 bps of U.S. transcatheter heart valve market share sequentially in 2Q on strong clinical data. Overall industry revenue growth accelerated for a second straight quarter to 51% vs. the prior year due to data released in April showing strong outcomes for valves from both Edwards and Medtronic. Edwards may continue to gain share and grow at a rapid pace due to its intermediate risk indication approved Aug. 18, which Medtronic may not get until 2H17.

Peer Comparison: Edwards Lifesciences and Medtronic are the only companies with valves approved in the U.S. Boston Scientific may get approval for its Lotus Edge in late 2017 while St. Jude Medical may not launch until 2018.

Edwards Rebounds as Heart Valve Adoption Grows Outside U.S.

08/29/16 - Edwards gained transcatheter valve market share outside the U.S. in 2Q, but was boosted by three extra selling days that added 500 bps to its sales growth. Excluding the extra days, overall industry revenue growth still accelerated over 450 bps vs. 1Q to 21% as adoption increased in smaller countries in Europe as well as in Germany. Boston Scientific may begin to gain market share from Edwards and Medtronic in 2017 with its new Lotus Edge valve due to its small size and ability to cut paravalvular leak.

Peer Comparison: Edwards Lifesciences is the leader of the transcatheter valve market in Europe with 53% revenue share, followed by Medtronic at 32%. Boston Scientific, St. Jude Medical, Symetis and JenaValve together account for another 15%.



Disclosure: We will not be taking a position in these companies until at least 72 hours after the post of this analysis.

Joseph S. Kalinowski, CFA





Email: joe@squaredconcept.net
Twitter: @jskalinowski
Facebook: https://www.facebook.com/JoeKalinowskiCFA/
Blog: http://squaredconcept.blogspot.com/
Web Site: http://www.squaredconcept.net/

No part of this report may be reproduced in any manner without the expressed written permission of Squared Concept Asset Management, LLC.  Any information presented in this report is for informational purposes only.  All opinions expressed in this report are subject to change without notice.  Squared Concept Asset Management, LLC is a Registered Investment Advisory and consulting company. These entities may have had in the past or may have in the present or future long or short positions, or own options on the companies discussed.  In some cases, these positions may have been established prior to the writing of the particular report. 

The above information should not be construed as a solicitation to buy or sell the securities discussed herein.  The publisher of this report cannot verify the accuracy of this information.  The owners of Squared Concept Asset Management, LLC and its affiliated companies may also be conducting trades based on the firm’s research ideas.  They also may hold positions contrary to the ideas presented in the research as market conditions may warrant.

This analysis should not be considered investment advice and may not be suitable for the readers’ portfolio. This analysis has been written without consideration to the readers’ risk and return profile nor has the readers’ liquidity needs, time horizon, tax circumstances or unique preferences been taken into account. Any purchase or sale activity in any securities or other instrument should be based upon the readers’ own analysis and conclusions. Past performance is not indicative of future results.



Trading Notes 12.6.16


Positive news from the services sector today. From Business Insider, “Two indicators on the US service sector released Monday showed strong new-business orders and hiring in November.

The Institute of Supply Management's purchasing manager's index (PMI) — based on a survey of executives — jumped to 57.2. It was the highest level since October 2015 and more than the forecast for 55.5.”

“The employment index spiked to 58.2 from 53.1, indicating that hiring increased at a much faster rate during November. “

“Markit Economics' PMI was 54.6 (54.8 forecast.) Service providers recorded the fastest pace of new-work growth in a year. 

Some companies told Markit that their clients were more willing to spend post-election, as a lot of the uncertainty had lifted. 

Service providers told Markit that they hired more workers in November, although the pace of job creation was weaker than the post-recession average rate. They remained optimistic about the economy's growth prospects over the next year.” 



From Calculated Risk, “This represents continued growth in the non-manufacturing sector at a faster rate. This is the 12-month high, and the highest reading since the 58.3 registered in October of 2015. The Non-Manufacturing Business Activity Index increased to 61.7 percent, 4 percentage points higher than the October reading of 57.7 percent, reflecting growth for the 88th consecutive month, at a faster rate in November. The New Orders Index registered 57 percent, 0.7 percentage point lower than the reading of 57.7 percent in October. The Employment Index increased 5.1 percentage points in November to 58.2 percent from the October reading of 53.1 percent. The Prices Index decreased 0.3 percentage point from the October reading of 56.6 percent to 56.3 percent, indicating prices increased in November for the eighth consecutive month at a slightly slower rate. According to the NMI®, 14 non-manufacturing industries reported growth in November. The Non-Manufacturing sector rebounded after a slight cooling-off in October. The majority of respondents' comments are positive about business conditions and the direction of the overall economy."”


Citigroup US Economic Surprise indicator has been spiking higher.


It appears much of the Trump Euphoria is starting to show up in the economic numbers.

Sentiment has also improved quite a bit. Post-election, respondents to the AAII Investment Survey have gotten bullish on equities suddenly. The Bull/Bear ratio has spiked.




Cam Hui from Humble Student of the Markets pointed out the NYSE McClellan Summation Index is far from overbought levels.


He also notes the seasonally strong period of stock performance right around this time of year.


Based on market activity it would appear a rotation has occurred into cyclical value stocks.



From Julius de Kempenaer, “Summary

·         Well defined sector rotation at the moment

·         Avoid Utilities, Staples and Health Care as they push deeper into the lagging quadrant

·         Watch Technology as it rotates inside the weakening quadrant

·         Financials are still leading, but relative trend is getting mature

·         Energy and Industrials inside leading quadrant offer potential

·         Prefer Materials over Discretionary inside the improving quadrant”

From IBD, “After two straight closes below the 50-day moving average, the Nasdaq popped 1%. Volume on the Nasdaq fell slightly from Friday's level, but it was still a solid showing for the tech index, which still carries a high distribution day count. IBD's market outlook was lowered a notch last week to "uptrend under pressure" when the Nasdaq fell below the 50-day line Thursday in heavy volume. The same day, the Philadelphia semiconductor index paid a visit to its 50-day line but closed just above it. It bounced off the line Friday and extended gains Monday. The message? Don't declare the chip sector dead just yet.”



From Stockcharts.com, “About two weeks ago the market blew through a line of resistance drawn across the previous all-time highs in August. Last week a new, all-time high was made, then the market met technical expectations -- it pulled back toward the point of breakout. So far, so good, but there are some problems.

First, the PMO topped. It is a shallow top that can easily be reversed by positive price action this week, but for now it is a negative.

Second, longer-term indicators are showing rather sharp negative divergences, and their readings are substantially lower than we might expect with the market making new, all-time price highs. For example, the Percent Buy Index (PBI) shows that only 63% of S&P 500 stocks are on Price Momentum Model (PMM) BUY signals. The other two indicators show a similar lack of participation. The flip side is that there is still plenty of room for the indicators to move higher.”


From Short Takes, “Positive Returns 97% Of The Time.

Based on current readings of their “sell side indicator”, Bank of America/Merrill Lynch (BOAML) recently wrote in a research note to clients:

“Historically, when our indicator has been this low or lower, total returns over the subsequent 12 months have been positive 97% of the time, with median 12-month returns of +25%,”



Recommended Stock Allocations Remain Low

The BOAML indicator is based on the recommended stock allocations inside portfolios. A typical benchmark equity allocation is 60%-65% of a portfolio. Presently, the recommended allocation is significantly below that range, coming in at 51%. If the recommendations moved back to the historical mean, as they typically do, money would continue to flow out of bonds and into stocks. More information about the BOAML signal can be found on Yahoo Finance.”

Interesting Articles regarding Trumponomics.

Can Trumponomics Fix What’s Broken? – Lance Roberts. He writes, “As you can imagine, I received quite  a few comments from readers suggesting that each percentage of tax cuts will lead to surging corporate earnings and economic growth. This was a point made by Bob Pisani recently on CNBC:

“The current 2017 estimate for the entire S&P 500 is roughly $131 per share. Thompson estimates that every 1 percentage point reduction in the corporate tax rate could ‘hypothetically’ add $1.31 to 2017 earnings.

So do the math: If there is a full 20 percentage point reduction in the tax rate (from 35 percent to 15 percent), that’s $1.31 x 20 = $26.20.

That implies an increase in earnings of close to 20 percent, or $157.”

Fair enough.

I don’t entirely disagree considering my recent prognostication of the S&P melting up to 2400 in the next few months.”

But he goes on to note that the Regan tax cuts didn’t have such an impact on corporate earnings.

“Importantly, as has been stated, the proposed tax cut by President-elect Trump will be the largest since Ronald Reagan. However, in order to make valid assumptions on the potential impact of the tax cut on the economy, earnings and the markets, we need to review the differences between the Reagan and Trump eras. My colleague, Michael Lebowitz, recently penned the following on this exact issue.

“Many investors are suddenly comparing Trump’s economic policy proposals to those of Ronald Reagan. For those that deem that bullish, we remind you that the economic environment and potential growth of 1982 was vastly different than it is today.  Consider the following table:”


“The differences between today’s economic and market environment could not be starker. The tailwinds provided by initial deregulation, consumer leveraging and declining interest rates and inflation provided huge tailwinds for corporate profitability growth.

As Michael points out, those tailwinds are now headwinds.

However, while Thompson’s have pulled a rather exuberant level of impact ($1.31 in earnings per 1% of tax rate reduction) a look back at the Reagan era suggests a different outcome.

The chart below shows the impact of the two rate reductions on the S&P 500 (real price) and the annualized rate of change in asset prices.”


“The next chart shows the actual impact to corporate earnings on an annualized basis.”


“In both cases, the effect was far more muted than what is currently being estimated by Wall Street analysts currently.

Furthermore, as I noted in this past weekend’s missive, given the primary expansion of the financial markets has been driven by monetary policy and artificially low interest rates, any benefit provided to earnings growth from lower taxes will be mitigated by reductions from changes in monetary policy. “



“The economic policy of President-elect Donald J. Trump is still a work in progress. But if campaign rhetoric is a reliable guide, reorienting trade policy may become one of the main goals of the new administration… A major theme of the report is concern about the trade deficit. In recent years, American imports have exceeded exports by about $500 billion a year. Mr. Navarro and Mr. Ross argue that if better policies eliminated this “trade deficit drag,” gross domestic product would be higher and more people would be employed.”

“That conclusion is correct, but only in a superficial sense. Gross domestic product is, by definition, the sum of consumption spending, investment spending, government purchases and the net exports of goods and services. If net exports rose from their current negative value to zero, and the other three components stayed the same, domestic production would increase and, consequently, so should employment.

But a fuller look at the macroeconomic effects of trade deficits suggests that things aren’t so simple.”

“The most important lesson about trade deficits is that they have a flip side. When the United States buys goods and services from other nations, the money Americans send abroad generally comes back in one way or another. One possibility is that foreigners use it to buy things we produce, and we have balanced trade. The other possibility, which is relevant when we have trade deficits, is that foreigners spend on capital assets in the United States, such as stocks, bonds and direct investments in plants, equipment and real estate.

In practice, these capital inflows from abroad have been large. Net foreign ownership of American capital assets has risen to about $8 trillion from $2.5 trillion at the end of 2010. American companies moving production overseas get a lot of attention, but this data shows that capital has, over all, moved in the opposite direction.”

“The trade deficit is inextricably linked to this capital inflow. When foreigners decide to move their assets into the United States, they have to convert their local currencies into American dollars. As they supply foreign currency and demand dollars in the markets for currency exchange, they cause the dollar to appreciate. A stronger dollar makes American exports more expensive and imports cheaper, which in turn pushes the trade balance toward deficit.

From this perspective, many of the policies proposed by Mr. Trump will increase the trade deficit rather than reduce it. He has proposed scaling back both burdensome business regulations and taxes on corporate and other business income. His tax cuts and infrastructure spending will most likely increase the government’s budget deficit, which tends to increase interest rates. These changes should attract even more international capital into the United States, leading to an even stronger dollar and larger trade deficits.”

“But what about those tariffs that Mr. Trump sometimes threatens to impose on foreign countries? They would certainly curtail the amount of international trade, but they are unlikely to have a large impact on the trade deficit.

When American consumers facing higher import prices from tariffs stop buying certain products from abroad, they will supply fewer dollars in foreign-exchange markets. The smaller supply of dollars will drive the value of the dollar further upward. This dollar appreciation offsets some of the effects of the tariff on imports, and it makes American exports less competitive in world markets.

But it doesn’t matter much, anyway, because in reality, trade deficits are not a threat to robust growth and full employment. The United States had a large trade deficit in 2009, when the unemployment rate reached 10 percent, but it had an even larger trade deficit in 2006, when the unemployment rate fell to 4.4 percent.

Rather than reflecting the failure of American economic policy, the trade deficit may be better viewed as a sign of success. The relative vibrancy and safety of the American economy is why so many investors around the world want to move their assets here. (And similarly, it is why so many workers want to immigrate here.)”




“President-elect Donald Trump and his emerging team are confident their proposed tax cuts and regulatory rollbacks will spark a dramatic upswing in economic growth. Two forces will make that tough: an aging population and stagnant productivity.”

“As a result, the nonpartisan Congressional Budget Office predicts roughly 2% annual growth for gross domestic product pretty much as far as the eye can see.”

“Economists agree that tax cuts and infrastructure spending could give the U.S. a boost especially in the short term. But doubt runs deep on both the left and the right that Mr. Trump can hot his ambitious target for long term growth”

“But over the long run, an economy’s potential growth rate all comes down to how much people are working and how productive they are. Deceleration in labor-force growth as the baby-boom generation begins to retire and workforce participation declines, plus a marked slowdown in productivity gains since the IT-fueled boom of the late 1990’s and early 2000’s, help explain the tepid recent growth trend and have prompted professional forecasters to lower their expectations for growth.”

“Achieving consistently stronger GDP growth would require some combination of expanding the workforce and boosting productivity growth – daunting tasks, especially on the demographic front.”




“The recent backup in yields is happening at an unfortunate time. In nominal terms, debt held by the public is at an an all-time high (approximately $14.3 trillion). As a % of GDP, debt held by the public is at the highest level going all the way back to 1962 (76.6%). The estimated term premium for 6-year government bonds (or a close approximation for the 70 month average maturity length of government bonds) has also increased from -70 bps on 7/8/2016 to 4 bps as of Friday. Toss in the fact that the average maturity of treasury debt has increased from 49 months on 12/31/2008 to 70 months as of 9/30/2016 and this all adds up to a situation where it is becoming much more expensive for the US government to finance its budget deficit. This is worrisome with the prospect of larger US deficits on the horizon.”






“"We are on the cusp of a period of rising interest rates," Evans told reporters after a speech in Chicago.

The yield on the benchmark 10-year Treasury note, which has risen to about 2.4 percent from below 2 percent before President-elect Donald Trump's surprise Nov. 8 victory, suggests markets are pricing in somewhat higher U.S. inflation, Evans said.

Evans has long been concerned that inflation, running at about 1.7 percent, is too low. He noted on Monday that while the U.S. labor market is "kind of tight," wage growth is weak.

Still, Evans is optimistic that conditions are ripe for inflation to rise back to the Fed's 2 percent target, especially given the policies that the incoming Trump administration has "earmarked" for the next few years. Trump has said he plans to cut taxes and improve U.S. bridges, roads and tunnels.”

“"An infrastructure plan would be terrific, that would be good," Evans said. "I think corporate tax rationalization would be a huge improvement."

Speaking to reporters later, Evans suggested he is not advocating a huge government infrastructure spending bill, saying, "you don't need explicit stimulus" with the jobless rate already so low.”

“The Republican businessman has said his policies would lift annual economic growth to 3 percent or 4 percent, or even more.

Evans, who rotates into a voting spot on the Fed's policy-setting panel next year, said that though it is possible to boost growth temporarily, keeping it there would be difficult without expanding the U.S. labor force or boosting productivity.

Otherwise, Evans said, it would be a challenge to boost the sustainable U.S. economic growth rate, which is currently about 1.75 percent.”



 Interesting Article on Corporate Buybacks


“Companies have finally hit the limit for buying up their own stock according to Deutsche Bank.

Buybacks have been the dominant driver of demand for stocks since 2009, according to HSBC research. And total activity in 2016 is set to total $450 billion, according to David Bianco, chief equity strategist at DB.

According to a note from Bianco, this is roughly the same level as 2014 and 2015.

Additionally, Bianco estimated that 20% of the S&P 500's earnings per share will come from buybacks. By shrinking the amount of stock outstanding, earnings are boosted on a per share basis.

According to Bianco, certain industries will see a more significant slowdown in buyback activity than others.

"Strains on maintaining buybacks (even dividends) will be at Energy, Industrials, and Materials," said Bianco. "But Healthcare and most of big cap Tech should be in a very good position to maintain buybacks or even boost them a bit as [free cash flow] at these sectors is healthy and these companies still very much have access to bank lines of credit and debt capital markets and low interest rates."


“The buyback boom may be in danger for a variety of reasons. Bank lending standards are getting tougher, the market believes interest rates are going to head higher, and the debt market may not be as benign as it has been.

On the other hand, while a variety of factors point to buybacks slowing, the absolute level of conditions is still accommodative. For instance, tightening from 0% interest rates to 1% interest isn't as big a deal as going from 5% to 6%, so the decline in buybacks may be limited.”



Bottom Line: We’re fully invested post-election and anticipate a strong market through the end of the year.



Joseph S. Kalinowski, CFA


Email: joe@squaredconcept.net
Twitter: @jskalinowski
Facebook: https://www.facebook.com/JoeKalinowskiCFA/
Blog: http://squaredconcept.blogspot.com/
Web Site: http://www.squaredconcept.net/



No part of this report may be reproduced in any manner without the expressed written permission of Squared Concept Asset Management, LLC.  Any information presented in this report is for informational purposes only.  All opinions expressed in this report are subject to change without notice.  Squared Concept Asset Management, LLC is a Registered Investment Advisory and consulting company. These entities may have had in the past or may have in the present or future long or short positions, or own options on the companies discussed.  In some cases, these positions may have been established prior to the writing of the particular report. 



The above information should not be construed as a solicitation to buy or sell the securities discussed herein.  The publisher of this report cannot verify the accuracy of this information.  The owners of Squared Concept Asset Management, LLC and its affiliated companies may also be conducting trades based on the firm’s research ideas.  They also may hold positions contrary to the ideas presented in the research as market conditions may warrant.



This analysis should not be considered investment advice and may not be suitable for the readers’ portfolio. This analysis has been written without consideration to the readers’ risk and return profile nor has the readers’ liquidity needs, time horizon, tax circumstances or unique preferences been taken into account. Any purchase or sale activity in any securities or other instrument should be based upon the readers’ own analysis and conclusions. Past performance is not indicative of future results.